Clinical Trial Update: Allogeneic Transplant in HIV Patients (BMT CTN 0903) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic transplant in HIV-positive patients with leukemia or lymphoma; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Leukemia
• Lymphoma

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2018-05-24